1-10 of 10
Wolfgang Hiddemann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy

Available to Purchase
Yun Wang, Yan-yu Cai, Tobias Herold, Run-cong Nie, Yu Zhang, Robert Peter Gale, Klaus H. Metzeler, Yun Zeng, Shun-qing Wang, Xue-yi Pan, Tong-hua Yang, Yuan-bin Wu, Qing Zhang, Zhi-jun Wuxiao, Xin Du, Zhi-wei Liang, Yong-zhong Su, Jing-bo Xu, Yong-qing Wang, Ze-lin Liu, Jian-wei Wu, Xiong Zhang, Bing-yi Wu, Ruo-zhi Xiao, San-bin Wang, Jin-yuan Li, Pei-dong Chi, Qian-yi Zhang, Si-liang Chen, Zhe-yuan Qin, Xin-mei Zhang, Na Zhong, Wolfgang Hiddemann, Qi-fa Liu, Bei Zhang, Yang Liang
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (1): 255–266.
https://doi.org/10.1158/1078-0432.CCR-20-3417
Published: 04 January 2021
View articletitled, An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
Open the PDF for An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy

Free
Magdalena Klanova, Mikkel Z. Oestergaard, Marek Trněný, Wolfgang Hiddemann, Robert Marcus, Laurie H. Sehn, Umberto Vitolo, Alexandra Bazeos, Valentin Goede, Harald Zeuner, Andrea Knapp, Deniz Sahin, Nathalie Spielewoy, Christopher R. Bolen, Andres Cardona, Christian Klein, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle-Rowson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (15): 4634–4643.
https://doi.org/10.1158/1078-0432.CCR-18-3270
Published: 01 August 2019
View articletitled, Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Open the PDF for Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy in another window
Includes: Supplementary data
Journal Articles

Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients

Free
Philipp A. Greif, Luise Hartmann, Sebastian Vosberg, Sophie M. Stief, Raphael Mattes, Ines Hellmann, Klaus H. Metzeler, Tobias Herold, Stefanos A. Bamopoulos, Paul Kerbs, Vindi Jurinovic, Daniela Schumacher, Friederike Pastore, Kathrin Bräundl, Evelyn Zellmeier, Bianka Ksienzyk, Nikola P. Konstandin, Stephanie Schneider, Alexander Graf, Stefan Krebs, Helmut Blum, Martin Neumann, Claudia D. Baldus, Stefan K. Bohlander, Stephan Wolf, Dennis Görlich, Wolfgang E. Berdel, Bernhard J. Wörmann, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1716–1726.
https://doi.org/10.1158/1078-0432.CCR-17-2344
Published: 02 April 2018
View articletitled, Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients
Open the PDF for Evolution of Cytogenetically Normal Acute Myeloid Leukemia During Therapy and Relapse: An Exome Sequencing Study of 50 Patients in another window
Includes: Supplementary data
Journal Articles

CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes

Free
Carola Reindl, Hilmar Quentmeier, Konstantin Petropoulos, Philipp A. Greif, Tobias Benthaus, Bob Argiropoulos, Gudrun Mellert, Sridhar Vempati, Justus Duyster, Christian Buske, Stefan K. Bohlander, Keith R. Humphries, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2238–2247.
https://doi.org/10.1158/1078-0432.CCR-08-1325
Published: 01 April 2009
View articletitled, CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
Open the PDF for CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes in another window
Includes: Supplementary data
Journal Articles

Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591

Free
Sridhar Vempati, Carola Reindl, Ulla Wolf, Ruth Kern, Konstantin Petropoulos, Vegi M. Naidu, Christian Buske, Wolfgang Hiddemann, Tobias M. Kohl, Karsten Spiekermann
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4437–4445.
https://doi.org/10.1158/1078-0432.CCR-07-1873
Published: 15 July 2008
View articletitled, Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591
Open the PDF for Transformation by Oncogenic Mutants and Ligand-Dependent Activation of FLT3 Wild-type Requires the Tyrosine Residues 589 and 591 in another window
Includes: Supplementary data
Journal Articles

Modeling the Pharmacodynamics of Highly Schedule-Dependent Agents: Exemplified by Cytarabine-Based Regimens in Acute Myeloid Leukemia

Free
Jan Braess, Michael Fiegl, Isolde Lorenz, Karin Waxenberger, Wolfgang Hiddemann
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7415–7425.
https://doi.org/10.1158/1078-0432.CCR-05-0360
Published: 20 October 2005
View articletitled, Modeling the Pharmacodynamics of Highly Schedule-Dependent Agents: Exemplified by Cytarabine-Based Regimens in Acute Myeloid Leukemia
Open the PDF for Modeling the Pharmacodynamics of Highly Schedule-Dependent Agents: Exemplified by Cytarabine-Based Regimens in Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Overexpression and Constitutive Activation of FLT3 Induces STAT5 Activation in Primary Acute Myeloid Leukemia Blast Cells

Free
Karsten Spiekermann, Ksenia Bagrintseva, Ruth Schwab, Karin Schmieja, Wolfgang Hiddemann
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2140–2150.
Published: 01 June 2003
View articletitled, Overexpression and Constitutive Activation of FLT3 Induces STAT5 Activation in Primary Acute Myeloid Leukemia Blast Cells
Open the PDF for Overexpression and Constitutive Activation of FLT3 Induces STAT5 Activation in Primary Acute Myeloid Leukemia Blast Cells in another window
Journal Articles

Radioimmunotherapy of Small Volume Disease of Colorectal Cancer Metastatic to the Liver: Preclinical Evaluation in Comparison to Standard Chemotherapy and Initial Results of a Phase I Clinical Study

Free
Thomas M. Behr, Alexandra L. Salib, Torsten Liersch, Martin Béhé, Christa Angerstein, Rosalyn D. Blumenthal, Afshin Fayyazi, Robert M. Sharkey, Bernhard Ringe, Heinz Becker, Bernhard Wörmann, Wolfgang Hiddemann, David M. Goldenberg, Wolfgang Becker
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3232s–3242s.
Published: 01 October 1999
View articletitled, Radioimmunotherapy of Small Volume Disease of Colorectal Cancer Metastatic to the Liver: Preclinical Evaluation in Comparison to Standard Chemotherapy and Initial Results of a Phase I Clinical Study
Open the PDF for Radioimmunotherapy of Small Volume Disease of Colorectal Cancer Metastatic to the Liver: Preclinical Evaluation in Comparison to Standard Chemotherapy and Initial Results of a Phase I Clinical Study in another window
Journal Articles

Low- versus High-Dose Radioimmunotherapy with Humanized Anti-CD22 or Chimeric Anti-CD20 Antibodies in a Broad Spectrum of B Cell-associated Malignancies

Free
Thomas M. Behr, Bernhard Wörmann, Martin Gramatzki, Joachim Riggert, Stefan Gratz, Martin Béhé, Frank Griesinger, Robert M. Sharkey, Hans-J. Kolb, Wolfgang Hiddemann, David M. Goldenberg, Wolfgang Becker
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3304s–3314s.
Published: 01 October 1999
View articletitled, Low- versus High-Dose Radioimmunotherapy with Humanized Anti-CD22 or Chimeric Anti-CD20 Antibodies in a Broad Spectrum of B Cell-associated Malignancies
Open the PDF for Low- versus High-Dose Radioimmunotherapy with Humanized Anti-CD22 or Chimeric Anti-CD20 Antibodies in a Broad Spectrum of B Cell-associated Malignancies in another window
Journal Articles

Oxaliplatin Pharmacokinetics during a Four-Hour Infusion

Free
Wolfgang Kern, Jan Braess, Bettina Böttger, Cornelia Christine Kaufmann, Wolfgang Hiddemann, Eberhard Schleyer
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (4): 761–765.
Published: 01 April 1999
View articletitled, Oxaliplatin Pharmacokinetics during a Four-Hour Infusion
Open the PDF for Oxaliplatin Pharmacokinetics during a Four-Hour Infusion in another window